Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: Nanomicelles co-loaded with doxorubicin and salvianolic acid A for breast cancer chemotherapy

Fig. 7

Evaluation of anticancer efficacy of various preparations in nude mice bearing human breast cancer MCF-7 cells (n = 8, mean ± SD) by relative tumor volume (A), tumor weight (B), and body weight change with time (C). In each group, the dosage was 2.5 mg/kg for DOX and 10.0 mg/kg for SAA equivalent. NC normal saline, Cocktail solution of free DOX and SAA, CPMSD compound micelles of DOX and SAA, DOX group free DOX solution. **p < 0.01 compared with the NC group and ##p < 0.01 compared with DOX group

Back to article page